Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million
07/05/2026 22:00
May 07 (Reuters) - Cipher Pharmaceuticals Q1 EBITDA USD 6.807 million. Q1 adjusted EBITDA USD 7.71 million
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million